The Valley Desk

ArticleInternational journal of radiation oncology, biology, physicsPublished

Safety and Biomarker Analysis of NRG-LU004: Phase I Trial of Accelerated or Conventionally Fractionated Radiation Therapy Combined With Durvalumab in Programmed Death Ligand-1-High Locally Advanced Non-small Cell Lung Cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Thomas Jefferson University Hospital, University of Pennsylvania, with Jefferson Health, Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
International journal of radiation oncology, biology, physics
Published
PubMed ID
42731785
PubMed Central ID
PMC13618747
Added to directory
Source checked

Report a correction or request removal